After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Sarepta Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Sarepta Therapeutics Inc is $2.39B. A total of 10.57 million shares were traded on the day, compared to an average of 7.19M shares.
In the most recent transaction, Sarepta Therapeutics, Inc. bought 9,265,312 shares of SRPT for 19.99 per share on Aug 13 ’25. In a previous transaction on Mar 12 ’25, Nicaise Claude sold 2,491 shares at 99.64 per share. SRPT shares that Director owns now total 27,812.
Among the insiders who bought shares, Nicaise Claude acquired of 2,491 shares on Mar 12 ’25 at a per-share price of $99.65. In another insider transaction, Wigzell Hans Lennart Rudolf sold 10,500 shares at $124.84 per share on Dec 12 ’24. Company shares held by the Director now total 22,840.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SRPT has a high of $138.81 and a low of $10.41.
As of this writing, SRPT has an earnings estimate of -$0.64 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $1.41 per share and a lower estimate of -$2.05. The company reported an EPS of $1.9 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $13.89, while its Total Shareholder’s Equity was $928.01M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 3.04.
